Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Technology transfer completed in Actelion/Merck renin alliance

March 8, 2004

Promising effects and safety profile found for PT-141 in erectile dysfunction

March 5, 2004

Uroxatral launched to primary-care physicians

March 5, 2004

Good safety and pharmacokinetic profile found for a buccal testosterone formulation

March 5, 2004

Endpoint met in phase IIa study of DMI-7958

March 4, 2004

Solifenacin reported both safe and effective in overactive bladder

March 4, 2004

Duloxetine improves voiding and quality of life of women with stress urinary incontinence

March 3, 2004

Acetylcysteine improves cardiovascular morbidity in renal failure

March 2, 2004

Sosei and Arachnova in licensing agreement in stress urinary incontinence

March 1, 2004

Uroflux completes phase II trial for BPH

Feb. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...